Back to Search
JEAN BELASCO, M.D.
M.D.
Pediatric Hematology & Oncology Physician
NPI: 1548282056Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
MD016359E(PA)
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
MD016359E(PA)
Research & Publications (20)
Hypofractionated moderate dose radiation, intrathecal chemotherapy, and repetitive reinduction/reconsolidation systemic therapy for central nervous system relapse of acute lymphoblastic leukemia in children.
PMID 10657874·Med Pediatr Oncol·2000
8-other
Supportive care: palliative care in children, adolescents, and young adults--model of care, interventions, and cost of care: a retrospective review.
PMID 11965934·J Palliat Care·2000
8-other
RNase E autoregulates its synthesis in Escherichia coli by binding directly to a stem-loop in the rne 5' untranslated region.
PMID 19320830·Mol Microbiol·2009
8-other
Variation in receipt of opioids by pediatric oncology patients who died in children's hospitals.
PMID 18989880·Pediatr Blood Cancer·2009
4-observational
Structure and biological function of the RNA pyrophosphohydrolase BdRppH from Bdellovibrio bacteriovorus.
PMID 19278661·Structure·2009
8-other
Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs.
PMID 18206964·Mol Cell·2008
6-review
Examining the influence of microRNAs on translation efficiency and on mRNA deadenylation and decay.
PMID 19215768·Methods Enzymol·2008
7-preclinical
PABLO analysis of RNA: 5'-phosphorylation state and 5'-end mapping.
PMID 19161839·Methods Enzymol·2008
8-other
Importance of translation and nonnucleolytic ago proteins for on-target RNA interference.
PMID 18771919·Curr Biol·2008
8-other
The bacterial enzyme RppH triggers messenger RNA degradation by 5' pyrophosphate removal.
PMID 18202662·Nature·2008
8-other
Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study.
PMID 17634493·J Clin Oncol·2007
3-trial
Initiation of RNA decay in Escherichia coli by 5' pyrophosphate removal.
PMID 17612492·Mol Cell·2007
8-other
Childhood intracranial ependymoma: twenty-year experience from a single institution.
PMID 17559078·Cancer·2007
8-other
Understanding parents' approaches to care and treatment of children with cancer when standard therapy has failed.
PMID 17557955·J Clin Oncol·2007
8-other
NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight.
PMID 17215493·Neurology·2007
8-other
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
PMID 16874765·Pediatr Blood Cancer·2007
8-other
Recurring polysomatic hemangiomatosis: a new syndrome?
PMID 16825996·J Pediatr Hematol Oncol·2006
5-case
MicroRNAs direct rapid deadenylation of mRNA.
PMID 16495412·Proc Natl Acad Sci U S A·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3401 CIVIC CENTER BLVD, CHILDREN'S HOSPITAL OF PHILADELPHIA - HEM/ONC
PHILADELPHIA, PA 19104 - Phone
- (215) 590-3535
Quick Facts
- NPI
- 1548282056
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile